Geybels were employees and shareholders of Novo Nordisk at the time of the analysis
Your prescriber might recommend stepping down to a lower dose temporarily and re-titrating up, which is the same approach used during initial treatment
, -
Once you know the big pharmaceutical companies are spending a lot of money looking for glucagon receptor antagonists and testing them, and GIP receptor antagonists and testing them, it requires a lot of gusto, a lot of lunacy and craziness to say, nah, I believe all these big pharmaceutical companies are wrong, my lab is doing the opposite. But now, the sentiment has drastically shifted and many companies are looking to co-agonist drugs to achieve over 20%, or even close to 30% weight loss
doi:10.1016/j.celrep.2016.11.051 44
In some cases, supportive care in a medical setting may be necessary, such as IV fluids for dehydration